Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy

Clinical Rheumatology

Volumn 31, Issue 8, 2012, Pages 1253-1258

  Song, Ran ^a   Choi, Hyun Mi ^b   Yang, Hyung In ^a   Yoo, Myung Chul ^b   Park, Yong Beom ^c   Kim, Kyoung Soo ^b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Disease modifying antirheumatic drugs (DMARDs); Rheumatoid arthritis (RA); Thymosin 4 (T 4); Tumor necrosis factor (TNF) blocker

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE; THYMOSIN BETA4; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; THERAPY RESISTANCE; TREATMENT RESPONSE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; THYMOSIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865989795     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2011-7     Document Type: Article

References (25)

1. Low TL, Goldstein AL (1982) Chemical characterization of thymosin beta 4. J Biol Chem 257:1000-1006
2. Low TL, Goldstein AL (1985) Thymosin beta 4. Methods Enzymol 116:248-255
3. Crockford D, Turjman N, Allan C, Angel J (2010) Thymosin beta4: Structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci 1194:179-189
4. Grant DS, Rose W, Yaen C, Goldstein A, Martinez J, Kleinman H (1999) Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3(2):125-135
5. Philp D, Goldstein AL, Kleinman HK (2004) Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 125(2):113-115
6. Philp D, St-Surin S, Cha HJ, Moon HS, Kleinman HK, Elkin M (2007) Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci 1112:95-103
7. Iguchi K, Usami Y, Hirano K, Hamatake M, Shibata M, Ishida R (1999) Decreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs. Biochem Pharmacol 57(10):1105-1111
8. Niu M, Nachmias VT (2000) Increased resistance to apoptosis in cells overexpressing thymosin beta four: A role for focal adhesion kinase pp 125FAK. Cell Adhes Commun 7(4):311-320
9. Moon EY, Im YS, Ryu YK, Kang JH (2010) Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator. Clin Exp Metastasis 27(8):601-609
10. Philp D, Scheremeta B, Sibliss K, Zhou M, Fine EL, Nguyen M, Wahl L, Hoffman MP, Kleinman HK (2006) Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol 208(1):195-200
11. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H et al (2002) Thymosinbeta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160(3):869-882
12. Blain EJ, Mason DJ, Duance VC (2002) The effect of thymosin beta4 on articular cartilage chondrocyte matrix metalloproteinase expression. Biochem Soc Trans 30(Pt 6):879-882
13. Golsteyn EJ, Fritzler MJ (1987) The role of the thymus-hypothalamus- pituitary-gonadal axis in normal immune processes and autoimmunity. J Rheumatol 14(5):982-990
14. Choi HM, Lee YA, Yang HI, Yoo MC, Kim KS (2011) Increased levels of thymosin beta4 in synovial fluid of patients with rheumatoid arthritis: Association of thymosin beta4 with other factors that are involved in inflammation and bone erosion in joints. Int J Rheum Dis 14(4):320-324
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324
16. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N (2007) Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 66(3):407-409
17. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137-145
18. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand Vet al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38(6):727-735
19. Badamchian M, Fagarasan MO, Danner RL, Suffredini AF, Damavandy H, Goldstein AL (2003) Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxininduced septic shock. Int Immunopharmacol 3(8):1225-1233
20. Girardi M, Sherling MA, Filler RB, Shires J, Theodoridis E, Hayday AC, Tigelaar RE (2003) Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. Immunology 109 (1):1-7
21. Sosne G, Qiu P, Christopherson PL, Wheater MK (2007) Thymosin beta 4 suppression of corneal NFkappaB: A potential antiinflammatory pathway. Exp Eye Res 84(4):663-669
22. Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74(2):293-299
23. Qiu P, Wheater MK, Qiu Y, Sosne G (2011) Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J 25(6):1815-1826
24. Zhang Y, Feurino LW, Zhai Q, Wang H, Fisher WE, Chen C, Yao Q, Li M (2008) Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 7(3):419-423
25. Goldstein AL, Hannappel E, Sosne G, Kleinman HK (2012) Thymosin β4: A multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 12 (1):37-51